BENGALURU, January 27, 2026: The venture capital engine is purring back to life this Tuesday as two heavyweights in the deep-tech and health-tech sectors, SpotDraft and 4baseCare, announced significant Series B infusions. While the sectors differ, one tackling the labyrinth of legal contracts and the other the genetic codes of cancer, the underlying theme is clear: AI is no longer a buzzword; it’s the bedrock of the next Indian unicorn stable.
SpotDraft: Keeping Legal Data Local
Legal-tech disruptor SpotDraft has officially tacked on $8 million from Qualcomm Ventures as a strategic Series B extension. This follows a massive $54 million haul from early 2025, signaling that the appetite for AI-driven contract management hasn’t just stayed steady, it’s intensifying.
Founders Shashank Bijapur and Madhav Bhagat are playing a clever hand by focusing on “on-device” AI. In an era of constant data leaks, SpotDraft’s ability to review contracts locally on hardware, recently demoed on Snapdragon X Elite laptops, removes the “cloud anxiety” for global enterprises.
The numbers back the hype: with customer growth at 100% and contract volumes surging by 173%, the company is rapidly scaling across the Americas and EMEA, even as it navigates the widening losses typical of high-growth SaaS scale-ups.
4baseCare: Decoding Cancer for the Global South
Simultaneously, the biotech sector caught a major tailwind. 4baseCare, a leader in precision oncology, closed the first tranche of its Series B at Rs 90 crore ($9.8 million). Led by veteran investors Ashish Kacholia and Lashit Sanghvi, the funding marks a pivotal moment for genomics in India.
4baseCare isn’t just running tests; they are building “OncoTwin,” an AI platform that creates a digital twin of a patient’s genomic profile to predict treatment outcomes. With a new partnership at the Memorial Sloan Kettering iHub in New York, Hitesh Goswami’s team is now taking Indian-grown genomic datasets to the world, targeting underrepresented populations in Southeast Asia and Latin America.
Closing the Gap: The Future of Domain-Specific AI
As venture capital flows back into high-moat startups, the success of SpotDraft and 4baseCare highlights a critical shift in the Indian ecosystem. Investors are moving away from general-purpose software in favor of specialized, vertically integrated AI that solves high-stakes problems, be it protecting corporate legal secrets or tailoring cancer treatments for the global south.
By securing these Series B tranches, both companies are now well-positioned to transition from regional players to global category leaders, proving that India’s deep-tech bench is ready for the world stage.
According to industry experts “The simultaneous funding of SpotDraft and 4baseCare is a masterclass in where the ‘Smart Money’ is headed in 2026. We are seeing a move away from ‘AI as a feature’ toward Sovereign AI, where data privacy in legal-tech and population-specific genomics in health-tech become the ultimate competitive moats. This is more than a funding win; it is a signal that the market values precision and privacy over generic scale.”
